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Summary 
The mechanism whereby somatostatin (SS) produces beneficial effects in 
established pancreatitis nduced by pancreaticobiliary duct ligation (PBDL) is still 
not clear. The aim of the work was to evaluate the possibility of a direct action of 
SS on pancreatic acinar cells from rats with acute pancreatitis. For this purpose, 
we studied the SS-receptor-adenylate cyclase system in pancreatic acinar 
membranes from both, control rats and rats with experimentally induced acute 
pancreatitis. On the other hand, it has been reported that cholecystokinin (CCK) 
diminishes the number of SS receptors in pancreatic acinar cells. Proglumide, a 
CCK receptor antagonist reduces the severity of acute pancreatitis in the rat. 
Therefore, we have also examined the effect of proglumide on the 
somatostatinergic system in controls and rats with acute pancreatitis. Fourteen 
hours after PBDL, the SS receptors, the capacity of the SS analogue SMS 201-995 
to inhibit forskolin-stimulated a enylate cyclase activity and PTX-catalyzed [3*P] 
ADP-ribosylation of the cq subunits of Gi proteins could not be detected in 
pancreatic acinar membranes. One month after reopening the closed 
pancreaticobiliary duct (PBD), the pancreas howed regeneration of acinar cells, 
and the above-mentioned parameters were significantly lower than in the control 
group. Two months after reopening the closed PBD, all these parameters had 
returned to control values. The administration of proglumide (20 mg/kg i.p.), a 
cholecystokinin receptor antagonist, accelerated pancreatic regeneration and 
approached all these parameters to control values one month after reopening the 
closed PBD. The present study suggests that the beneficial effects of SS on 
established pancreatitis nduced by PBDL may not be due to a direct action of the 
peptide on pancreatic acinar cells at least at 14 hours after PBDL. In addition, 
these findings suggest that in established pancreatitis the effect of proglumide on 
the SS receptor-adenylate cyclase system could be due to its action on pancreatic 
regeneration. 
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A variety of receptors on pancreatic acinar and ductal cells regulate both pancreatic 
exocrine secretion and intracellular processes. These receptors are potential sites of action for 
therapeutic agents in the treatment of pancreatitis (1). Some cholecystokinin (CCK) receptor 
antagonists, which may reduce the levels of metabolic “stress” in acinar cells, have been shown 
to mitigate the severity of acute pancreatitis na number of models (2,3,4). Somatostatin (SS) and 
its analogs also mitigate the severity of acute pancreatitis. The use of SS in acute pancreatitis was 
first suggested in 1975 (5). Previous studies investigating the effects of SS on experimentally 
induced pancreatitis have provided conflicting results (6,7,8). SS as well as its long-acting 
analogue have been reported to improve survival rate and pancreatic histopathology in rats with 
pancreaticobiliary duct ligation (PBDL)(7). 
The mechanism whereby SS produces beneficial effects in established pancreatitis nduced 
by PBDL is still not clear. Recent studies have shown the existence of SS receptors on pancreatic 
acinar cells (9,10), indicating that SS acts directly on acinar cells. These receptors are coupled 
to the adenylate cyclase (AC) enzyme system via a guanine nucleotide inhibitory protein Gi (11). 
The aim of the present study was to evaluate the possibility of a direct action of SS on pancreatic 
acinar cells from rats with acute pancreatitis. Therefore, we studied the SS receptor-AC system 
in pancreatic acinar membranes from controls and rats with acute pancreatitis. On the other hand, 
since PBDL-induced acute pancreatitis n rats is associated with a rise in plasma CCK levels (12) 
and proglumide, a CCK-receptor antagonist reduces the severity of acute pancreatitis n the rat 
(3), we have also studied the effect of proglumide on the somatostatinergic system in control rats 
and rats with acute pancreatitis. Thus, the present study examined the binding of a radioiodinated 
stable SS-14 analogue, SMS 204-090 or [Tyti]SMS, to its specific receptors, the ability of the 
SS analogue SMS 201995 to inhibit forskolin (FK)-stimulated AC activity and pertussis toxin 
(PTX)-catalyzed [32P] ADP-ribosylation of the (Y subunits of Gi proteins in rat pancreatic acinar 
membranes fourteen hours after PBD ligation (PBDL) and one or two months after reopening the 
closed PBD. SS in the pancreas is localized in the (so-called) D -cells (13,14) in the islets of 
Langerhans (15). Because there is a close interaction between the islets and the exocrine tissue, 
which appears in part to be mediated by an insulinoacinar portal system (16,17), SS-like 
immunoreactivity (SSLI) in the pancreas of these animals was also studied. 
Materials and Methods 
Chemicals 
The stable SS analogue SMS 201-995 and its tyrosine analogue Tyf-SMS or SMS 204-090 
were kindly donated by Sandoz Ltd., (Basel, Switzerland). Collagenase (from Closfridizun 
histoliticum) was obtained from Serva Fine Chemicals (Tebu, France). Proglumide, bacitracin, 
phenylmethylsulphonylfluoride (PMSF), guanosine triphosphate (GTP), 3-isobutyl-l- 
methylxanthine (IBMX), pertussis toxin (PTX) and bovine serum albumin (BSA) were purchased 
from Sigma (St. Louis, MO, USA). Carrier-free Na[‘*‘IJ (IMS 300, 100 mCi/ml) and the rabbit 
antibody used in the radioimmunoassay technique were purchased from the Radiochemical Center 
(Amersham, U.K.). This antiserum was raised in rabbits against SS-14 conjugated to BSA and 
is specific for SS, but since SS-14 constitutes the C-terminal portion of both SS-25 and’SS-28, 
the antiserum does not distinguish between these three forms. In the rat pancreas, SS-14 is the 
predominant molecular species, constituting 95% of total SS, whereas SS-28 seems to comprise 
less than 5% of the immunoreactivity (18). All other agents were of the highest purity 
commercially available. 
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Experimental animals 
The animals experiments performed in the present study were conducted under the 
guidelines of the Animal Care Committee of Alcala University, Medical School and the 
experimental protocols have been approved. Male Wistar rats weighing 200-250 g were 
anesthetized with 40 mg/kg of ketamine hydrochloride administered intramuscularly. The 
abdomen was opened by a midline incision and the proximal duodenum exposed. Acute 
pancreatitis was induced by ligation of the PBD with a silk string at its point of entry into the 
duodenum, thereby allowing reflux of bile to the pancreas (19). Subsequently, the abdominal wall 
was closed in two layers using a non-absorbable suture. Fourteen hours after ligation, twenty rats 
were sacrificed and another forty rats were subjected to a second laparotomy to reopen the closed 
PBD by removing the silk. These rats were sacrificed one and two months after reopening the 
closed PBD. Control rats were submitted to a sham operation. Proglumide, a CCK receptor 
antagonist, was administered intraperitoneally (20 mg/kg) to thirty rats one hour before and six 
hours after PBD occlusion. The drug dose was selected according to the effective dose reported 
in previous studies (20). The animals were decapitated atthe times indicated and the pancreas was 
removed and trimmed free of fat, connective tissue and lymph nodes. 
Histological study 
For light microscopy, fragments of pancreas were quickly removed and fixed two days 
at room temperature in 10% formaldehyde buffered to pH 7.0. The fragments were subsequently 
embedded in paraffin, sectioned in 9 pm slices and stained by the Masson trichrome method. 
Preparation of rat pancreatic acinar membranes 
Dispersed pancreatic acini were obtained from male Wistar rats after enzymatic 
degradation of the organ with 0.2 units of collagenase/ml in an oxygenated Krebs-Ringer medium 
as described by Amsterdam et al. (21). After thorough washing by sedimentation, acini were 
transferred to 0.3 M sucrose. In 0.3 M sucrose, the acini were homogenized at 4°C by use of a 
Potter homogenizer following the Meldolesi et al. method (22). After sedimentation at 1,500 x 
g for 12 min, the homogenized membranes were resuspended in 1.56 M sucrose. This suspension 
was overlaid with 0.3 M sucrose, and centrifuged at 105,000 x g for 150 min. The plasma 
membrane-enriched fraction collected from the interphase was diluted with distilled water and 
centrifuged at 15,000 x g for 30 min. The supematant was discarded and the pellet was 
resuspended in 50 mM Tris/HCl pH 7.4, 0.01 mg/ml bacitracin, 0.2 mM CaCl, and stored at - 
70°C. An aliquot was taken for protein determination by the method of Lowry et al. (23). 
Binding of ~zl-Tyr’/SMS 
Binding of [“‘I-Ty?]SMS was assayed on pancreatic acinar membranes from Wistar rats 
by a modified method (24). The stable SS-14 analogue, SMS 204-090 or [Ty?]SMS, which shares 
the biological properties of SMS 201-995 and has proven valuable in the characterization f SS-14 
binding to receptors in rat pancreatic acinar (10) and brain (25) membranes, was radioiodinated 
by the chloramine-T-method and purified by HPLC according to Antoniotti et al. (26). Its specific 
radioactivity was found to be 900 Ci/mmol. 
Binding of [‘2’I-Ty?]SMS to pancreatic acinar membranes was carried out in a total 
volume of 250 ~1 in 50 mM Tris-HCl buffer @H 7.4) containing 0.5 mM MgCl,, 3 mM NaCl, 
0.2 mM CaCl,, 0.2% (wt/vol) BSA, 0.5 mg/ml bacitracin and 0.3 mg/ml soybean trypsin 
inhibitor (binding buffer). Plasma membranes (36 pg protein/ml) were incubated for 90 min at 
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20°C with 35 pM [‘251-Tyf]SMS in the absence or presence of 0.001-10 nM unlabelled SMS 201- 
995. Bound and free ligand were separated by centrifugation at 11,000 x g for 4 min at 4°C in 
a microcentrifuge. Radioactivity in the pellet was measured with a gamma scintillation counter. 
Non-specific binding was estimated as membrane-associated radioactivity in the presence of 1 PM 
SMS and specific binding was calculated as the difference between total and non-specific 
membrane-associated radioactivity. 
Adenylate cyclase assay 
AC activity was measured as previously reported (27) with minor modifications. Briefly, 
rat pancreatic acinar membranes (0.12 mg protein/ml) were incubated with 1.5 mM ATP, 5 mM 
MgSO.,, 1 PM GTP and an ATP-regenerating system (7.5 mg/ml creatine phosphate and 1 mg/ml 
creatine kinase), 1 mM IBMX, 0.1 mM PMSF, 1 mg/ml bacitracin, 1 mM EDTA, and tested 
substances (10e9 M SMS 201-995 or 18’ M FK) in 0.1 ml of 0.025 M triethanolamine./HCl buffer 
@H 7.4). After a 30 min incubation at 3fPC, the reaction was stopped by heating the mixture for 
3 min. After refrigeration, 0.2 ml of an alumina slurry (0.75 g/ml in triethanolaminelHC1 buffer, 
pH 7.4) was added and the suspension centrifuged. The supematant was taken for assay of cyclic 
AMP by the method of Gilman (28). 
Pertussis toxin-catalyzed ALIP ribosylation 
The pertussis-toxin (PTX)-catalyzed ADP- ribosylation was carried out as previously 
reported (29). After PTX activation, membranes (0.8 mg protein /ml) were incubated with PTX 
(16 pg/ml) in 100 mM Tris-HCl buffer (pH 8.0), containing 10 mM thymidine, 1 mM ATP, 100 
PM GTP, 2.5 mM MgCl,, 1 mM EDTA, 2 PM [32P]NAD’ (3OCi/mmol) and an ATP- 
regenerating system. After 30 min at 3O”C, the reaction was stopped by addition of 1 ml of ice- 
cold 100 mM Tris-HCl buffer (pH 8.0), proteins were sedimented by centrifugation for 10 min 
at 30,000 x g and solubilized with 0.1 ml 60 mM Tris-HCl buffer (pH 6.8) containing 10% 
glycerol, 0.001% bromophenol blue and 3% SDS (SDS-sample buffer). After heating for 30 min 
at WC, the suspension was centrifuged for 10 min at 100,000 x g and aliquots of the supematant 
were submitted to SDS-PAGE using the procedure of Laemmli (30) as previously described (31). 
The gels were run, fixed, dried and exposed to Dupont films (cronex 4) for l-7 days at -80°C 
using an intensifying screen. 
Tissue eXtraction and SS raa?oimmunoassay 
[Tyr”]SS was radioiodinated by chloramine-T iodination according to the method of 
Greenwood (32). Separation of iodinated SS from unincorporated iodine was carried out on a 
Sephadex G-25 (fine) column equilibrated and eluted with 0.1 M acetic acid in BSA (0.1% w/v). 
Its specific activity was found to be 600 Ci/mmol. 
For SSLI measurement, the pancreas were rapidly homogenized in 1 ml 2 M acetic acid 
using a Brinkman polytron (setting 5, 30s). The extracts were boiled for 5 min, cooled in an ice- 
chilled water-bath, and aliquots (100 ~1) were removed for protein determination (23). The 
homogenates were subsequently centrifuged at 15,000 x g for 15 min at 4°C and the supematant 
was neutralized with 2 M NaOH. The extracts were stored at -70-C until assay. The SS 
concentration was determined in tissue extracts by a modified radioimmunoassay method (14), 
with a sensitivity limit of 10 pg/ml. Incubation tubes prepared in duplicate contained 100 ~1 
samples of tissue extracts or standard solutions of O-500 pg of cyclic SS-14 diluted in phosphate 
buffer (0.05 M, pH 7.2 containing 0.3% BSA, 0.01 M EDTA), 200 ~1 of appropriately diluted 
anti-SS-serum and 100 ~1 of freshly prepared [‘2SI-Tyr”]SS diluted in buffer to give 6,000 cpm 
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(equivalent to 5-10 pg), in a final volume of 0.8 ml. All reagents as well as the assay tubes were 
kept chilled on ice before their incubation at 4°C 48 h. Bound hormone was separated from free 
hormone by the addition of 1 ml of dextran-coated charcoal (dextran T-70,0.2% w/v, Pharmacia, 
Uppsala, Sweden; charcoal: Norit A, 2% w/v, Serva, Feinbiochemica, Heidelberg, Germany). 
Serial dilution curves for the samples were parallel to the standard curve. The intra and inter- 
assay variation coefficients were 6.0 and 8.8% respectively. 
Data analysis 
The LIGAND computer program (33) was used to analyze the binding data. The use of 
this program made it possible to select the models of receptors which best fit a given set of 
binding data. The same program was also used to present data in the form of Scatchard plots (34) 
and to compute the values for receptor affinity (Kd) and density (Bmax) that best fit the sets of 
binding data for each rat. Statistical comparisons of all the data were analyzed by ANOVA and 
the Newman-Keuls t-test. Means among groups were considered significantly different when the 
p value was less than 0.05. Each individual experiment was performed in duplicate. 
Fourteen hours after PBD ligation, several features of acute pancreatitis were present; 
edema, inflammatory cell infiltration, necrosis and hemorrhage were observed around intralobular 
and interlobular ducts and, less frequently, in a perilobular location (Fig. 1, 1B). One month after 
reopening the closed PBD, the pancreas howed regeneration of acinar cells (Fig. 1, 1C). Two 
months after reopening the closed PBD, the pancreatic structure was fully restored (data not 
shown). 
Specific binding of [r2’I-Tyti]SMS to pancreatic acinar membranes changed linearly with 
protein concentration and was time-dependent i  all experimental groups. An apparent equilibrium 
was observed between 60 and 120 min at 20°C (data not shown). All subsequent binding 
experiments were therefore conducted at 20°C for 90 min. Ligand degradation i  the incubation 
medium was determined to rule out the possibility of different [i2-‘I-Ty?]SMS degrading activities 
in each of the preparations which might have affected the interpretation of the results. Pancreatic 
acinar membranes from each experimental group showed a similar peptide degradation capacity 
and the values varied by no more than 10% among experimental groups. 
Increasing concentrations of unlabelled SMS 201-995 competitively inhibited the specific 
binding of [1251-Ty?]SMS to rat pancreatic acinar membranes inboth control and treated rats (Fig. 
2, left panel). Scatchard plots obtained from the saturation curves provided a straight line, 
indicating a single population of high-affinity saturable binding sites (Fig. 2, right panel). Table 
1 shows the corresponding equilibrium parameters for the SS receptors. Fourteen hours after 
occlusion of the PBD, no SS receptors were detected and one month after reopening the closed 
PBD, the number of SS receptors and their affinity was still significantly lower than in the control 
group. Two months after reopening the closed PBD, the number of SS receptors and the affinity 
constant had returned to control values. 
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FIG. 1 1 
Time course of histological changes after pancreaticobiliary duct ligation (PBDL) 
and reopening the closed pancreaticobiliary duct (PBD) x 475. Control rats killed 
fourteen hours after sham-operation show no changes (1A). Fourteen hours after 
PBDL, there is a mild interstitial edema, inflammatory cell infiltration, necrosis 
and hemorrhage. Arrows indicate destroyed pancreatic acinar tissue (1B). One 
month after reopening the closed PBD, the previous histologic findings were 
normalized (1C). The administration of proglumide (20 mg/kg i.p.) had no 
observable effect in control rats (2A) and rats sacrificed fourteen hours after PBDL 
(2B). However, its administration did accelerate pancreatic regeneration at one 
month after reopening the closed PBD (2C). 
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TABLE I 
Pancreatic somatostatin-like immunoreactive (SSLI) content and equilibrium parameters for [‘*‘I- 
Ty?]SMS binding to rat pancreatic acinar membranes atfourteen hours after pancreaticobiliary 
duct ligation (PBDL), one and two months after reopening the closed pancreaticobiliary duct 
(PBD) and to pancreatic acinar membranes from rats treated with proglumide (20 mg/kg i.p.) one 
hour before and six hours after PBD occlusion. 
Groups 
SS receptors SSLI 
Bmax Kd 
14 hours 
Control 
Proglumide 
PBDL 
PBDL + 
Proglumide 
1 month 
Control 
Proglumide 
Reopening 
Reopening + 
Proglumide 
2 months 
Control 
Proglumide 
Reopening 
Reopening + 
Proglumide 
4646k80 0.28kO.02 3.22kO.30 
4678& 117 0.33kO.02 3.17kO.32 
ND ND 8.06+0.84*** 
ND ND 3.08f0.09 
4718t95 0.29kO.03 3.96kO.46 
4665f 147 0.33~0.02 3.84A0.33 
2354f246*** 0.40+0.01* 9.69+0.05*** 
4086+ 84** 0.46+0.01* 4.80f0.08 
4663 f 66 0.34+0.01 4.21 f0.52 
4585f 154 0.36+0.01 4.OOkO.46 
4547f 194 0.35kO.03 3.19f0.33 
4368f268 0.40+0.02 5.55kO.23 
Binding parameters were calculated from Scatchard plots by linear regression. Units for SSLI are 
ng of SS per mg of protein, units for Kd are nM and units for Bmax are femtomoles of SMS 
bound per mg of protein. Each value is the mean _+ S.E.M. of six rats per group performed in 
duplicate. Statistical comparison versus control: *p<O.O5, **p<O.Oi, ***p<O.OOl. ND: not 
detectable. 
The functional coupling of SS receptors to the AC system was studied in pancreatic acinar 
membranes from control and treated rats. Fourteen hours after PBDL both basal and FK- 
stimulated AC activity were not detectable in PBD-ligated rats and were lower one month after 
reopening of the closed PBD as compared to controls (Tables 2 and 3). The fold FK stimulation 
over basal AC activity, however, was similar in all experimental groups, in sharp contrast with 
the SS effects. Since FK is believed to act directly upon the catalytic subunit of AC, these data 
suggest that the activity of AC is independent per se of pancreatic regeneration. The capacity of 
SMS 201-995 to inhibit basal and FK-stimulated AC activity in controls and at fourteen hours 
after PBDL and at one and two months after reopening of the PBD is shown in Tables 2 and 3. 
It is to be noted that SMS 201-995 did not modify basal AC activity although it did inhibit FK- 
stimulated AC activity. The inhibitory effect of SMS 201-995 on FK-stimulated AC activity was 
not detectable at fourteen hours after PBDL and markedly decreased in pancreatic acinar 
membranes atone month after reopening of the PBD as compared to control animals and returned 
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to control values two months after the reopening. 
The study of PTX-catalyzed ADP-ribosylation showed a decrease in a 41 kD PTX 
substrate, presumably the a1 subunit of Gi, in rat pancreatic acinar membranes one month after 
reopening the closed PBD when compared with the control group (Fig. 3). Two months after 
reopening the closed PBD, this parameter returned to control values (data not shown). Fourteen 
hours after PBD ligation, PTX-catalyzed ADP-ribosylation was not detectable (Fig.3). 
Pancreatic SSLI content was increased fourteen hours after PBDL and one month after 
reopening the closed PBD. Two months after reopening the closed PBD, pancreatic SSLI content 
had returned to control values (Table 1). 
TABLE II 
Effect of SMS 201-995 (10’ M) and forskolin (FK) (10’ M) on adenylate cyclase (AC) activity 
(pmol cAMP/min/mg protein) in pancreatic acinar membranes from control rats, rats with 
pancreaticobiliary duct ligation (PBDL), rats treated with proglumide (20 mg/kg i.p.) one hour 
before and six hours after PBDL (PBDL +PG) and proglumide-treated rats (PG). All the groups 
were studied at fourteen hours after PBDL. 
Groups Control PG PBDL PBDL 
+ PG 
hours 14 
Basal activity 
+ 1O-9 M SMS 
% SMS inhibition of 
basal activity 
+lO-’ M FK 
Fold FK stimulation 
over basal 
10’ M FK + 
l(r9 M SMS 
% SMS inhibition of 
FK stimulation 
17.8 f 1.4 18.2 f 2.0 ND ND 
15.2 f 0.9 15.6 + 2.0 ND ND 
14.6 + 1.2 14.3 f 1.8 ND ND 
36.9 + 0.7 36.5 + 1.4 ND ND 
2.1 + 0.7 2.0 f 0.6 ND ND 
27.7 + 1.1 26.1 f 2.9 ND ND 
24.9 + 1.4 28.5 f 3.2 ND ND 
Experiments were performed as described in Methods. Values represent the mean f S.E.M. of 
six rats per group performed in duplicate. ND : not detectable. 
Proglumide administration (20 mg/kg i.p.) one hour before and six hours after occluding 
the PBD had no observable ffect on any of the parameters studied in rats sacrificed fourteen 
hours after PBDL. However, its administration accelerated pancreatic regeneration one month 
after reopening the closed PBD (Fig. 1, 2C) and the pancreatic SSLI content, the number of [lz51- 
Ty?]SMS-binding receptors and the ability of the SS analogue SMS 201-995 to inhibit FK- 
stimulated AC activity in rat pancreatic acinar membranes (Fig. 2, Tables 1, 2 and 3) approached 
control values, although remaining significantly lower than in controls. Two months after 
reopening the closed PBD, proglumide administration had no observable ffect on the parameters 
studied (Tables 1 and 3). Proglumide had no effect on the SS-receptor-effector system. 
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TABLE III 
Effect of SMS 201-995 (log M) and forskolin (FK) (lo5 M) on adenylate cyclase (AC) activity 
(pm01 cAMFVmin/mg protein) in pancreatic acinar membranes from control rats (n =6), rats after 
reopening the closed pancreaticobiliary duct (PBD) one and two months after occlusion (n=6), 
rats treated with proglumide (PG) (20 mg/kg i.p.) one hour before and six hours after PBD 
occlusion and studied one and two months after reopening the closed PBD (n=6), and 
proglumidetreated rats (n = 6). 
Groups Control PG Reopening Reopening 
+ PG 
1 month 
Basal activity 18.7 + 1.5 19.1 f 1.1 
+ 10’ M SMS 16.0 f 1.1 16.3 f 1.2 
96 SMS inhibition of 
basal activity 14.4 * 0.9 14.7 f 1.0 
+lO-‘MFK 39.3 rt 1.8 40.0 f 1.4 
Fold FK stimulation 
over basal 2.1 + 0.7 2.1 + 0.6 
lo5 M FK + 
10’ M SMS 29.4 + 1.7 29.1 + 1.6 
46 SMS inhibition of 
FK stimulation 25.2 f 1.4 27.3 + 2.1 
2 
Basal activity 17.9 + 0.7 18.2 + 1.2 
+ lo-’ M SMS 15.3 f 0.9 15.5 + 1.1 
96 SMS inhibition of 
basal activity 14.5 + 0.6 14.8 f 1.0 
+l@‘MFK 38.2 f 1.3 37.8 + 3.1 
Fold FK stimulation 
over basal 2.1 + 0.7 2.1 + 0.7 
10 M FK + 
10’ M SMS 28.0 f 1.3 28.3 f 1.9 
96 SMS inhibition of 
FK stimulation 26.7 f 1.1 25.1 + 1.7 
10.3 + 1.0** 
9.0 * 0.5*** 
12.6 + 0.8 
23.7 f 2.7** 
2.3 + 0.6 
20.2 + 1.7** 
14.8 + 1.5*** 
18.1 f 0.2 
15.4 f 0.2 
14.9 + 0.2 
36.2 f 2.3 
2.0 + 0.6 
26.4 f 1.7 
27.1 f 1.6 
6.1 + 0.5*** 
5.7 + 0.5*** 
6.6 & 0.4*** 
15.0 f 2.1*** 
2.5 f 0.8 
13 4 + 1 9*** * - * 
10 7 + 0 9*** * - * 
18.2 + 1.2 
15.5 + 1.2 
14.8 + 1.0 
37.5 * 3.0 
2.1 f 0.6 
28.4 + 2.3 
24.3 + 1.9 
Experiments were performed as described in Methods. Values represent the mean It S.E.M. of 
six rats per group performed in duplicate. Statistical comparison versus control: **p<O.Ol, 
***p<o.O01. 
Discussion 
Damaging pancreatic tissue by ligating the pancreaticobiliary duct (PBD) at its point of 
entry into the duodenum leads to histological changes consistent with acute pancreatitis (35) and 
reopening the obstructed PBD permits regeneration of the acinar cells from duct cells (35). Thus, 
reopening the obstructed PBD is a model used to study pancreatic regeneration (35). Fourteen 
hours after PBDL, histological changes consistent with acute pancreatitis were observed, in 
agreement with other authors (35,7). These changes disappeared one month after reopening the 
closed PBD. Thus, the present study provides evidence that the chain of events leading to 
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irreversible pancreatitis is not initiated during the first fourteen hours of PBDL. This conclusion 
agrees with studies of Oshio et al.(36) and Kueppers et al. (37). In addition, these findings 
indicate that regeneration was possibly almost completed within one month after removing the 
obstruction and reestablishing the flow. In addition, in other experimental models, spontaneous 
regeneration was still incomplete after 23 days (2). 
A striking feature of the present investigation is the marked increase in pancreatic SSLI 
content fourteen hours after PBDL and one month after removing the obstruction and 
reestablishing the flow. To our knowledge, there are no studies on pancreatic SSLI content in 
acute pancreatitis and during pancreatic regeneration. However, Larsen et al. (38) have shown 
that plasma SS concentrations were persistently elevated in patients with chronic pancreatitis (2). 
With respect to a possible mechanism for the increased pancreatic SSLI content, previous studies 
in rats have demonstrated that CCK stimulates pancreatic SS release in vitro (39) and in vivo (40) 
and that chronic administration of the CCK analogue, caerulein, results in a marked increase in 
pancreatic SSLI content (41). It is possible, therefore, that the change in pancreatic SSLI 
concentration observed in this study is the result of the increased plasma CCK concentrations 
described in obstruction-induced acute pancreatitis (12). 
-4- 
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m 
I I I 
0.0 0.09 0.18 
0.6 
[SMS 201-9951, -log M Bound, nM 
FIG. 2 
Left panel: Competitive inhibition of specific [?-Ty?]SMS binding to rat 
pancreatic acinar membranes by unlabelled SMS 201-995. Points correspond to 
control rats (0), rats after reopening the closed pancreaticobiliary duct (PBD) one 
month after occlusion (O), rats treated with proglumide one hour before and six 
hours after the occlusion of PBD and studied one month after reopening the closed 
PBD (A) and proglumide-treated rats (A). Each point is the mean of six rats per 
group performed in duplicate. Results express the value of a pool of control groups 
since maximal binding capacity and dissociation constant values were not affected 
in the control groups. Right panel: Scatchard analysis of the same data. The kinetic 
constants calculated by Scatchard analysis are given in Table 1. 
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Coinciding with features of acute pancreatitis such as pancreatic edema, inflammation and 
necrosis at fourteen hours after PBDL, the SS receptors, the capacity of the SS analogue SMS 
201995 to inhibit FK-stimulated AC activity and PTX-catalyzed p2P] ADP-ribosylation of the 
(Y, subunits of Gi proteins could not be detected in pancreatic acinar membranes. 
Despite histological improvement at one month after reopening the PBDL, the number of 
SS receptors in the exocrine pancreas i  still decreased. The reason why the SS receptors are less 
abundant in the regenerating pancreas than in quiescent adult pancreatic acinar cells and the 
mechanism of this change are unknown. However, several alternative xplanations must be 
considered which include the modulation of apparent receptor number by hormones or other 
factors or an intracellular process that results in the loss of SS receptors. 
14 hours 1 awnth 
con&et PBDL contra! PBl.x 
* u@* t 41 kD 
Pertuasir 
to)& -+ +- -+ f- 
14 hours 1 month 
t&n - + + - - + + - 
FIG. 3 
Autoradiographs of r2P]ADP-ribosylated pancreatic acinar membrane proteins. 
Pancreatic acinar membranes (0.8 mg protein/ml) from control rats, rats with 
pancreaticobiliary duct ligation (PBDL) and sacrificed at fourteen hours after 
PBDL or one month after reopening the closed pancreaticobiliary duct (PBD), and 
from proglumide-treated rats with or without PBDL and studied fourteen hours 
after PBDL or one month after reopening the closed PBD, were incubated for 30 
min at 30°C in the presence of 2 PM [32PJNAD’ (30 Ci/mmol), with (+) or 
without (-) pertussis toxin (16 pg/ml). These experiments are representative of 
three others. For details, see Materials and Methods section. 
Although the mechanisms responsible for these changes in SS binding are not clear, it is 
well established that high SS levels lead to decreased SS binding (9). The increase of pancreatic 
SSLI content one month after releasing the PBDL was found to be associated with a reduction 
of the number of SS receptors in pancreatic acinar cell membranes. These results suggest that an 
increase in endogenous SSLI content leads to desensitization r down-regulation of SS receptors 
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in the exocrine pancreas. In this regard, SS receptors on rat pancreatic acinar cells are regulated 
by SS in vivo, as evidenced by the decreased binding in streptozotocin-induced diabetic rats, 
characterized by hypersomatostatinemia (9). SS-14 receptor down-regulation i  vitro has also been 
reported in AtT-20 mouse pituitary tumor cells (42). In addition, SS binding in the exocrine 
pancreas is also inhibited by Ca2+-mobilizing pancreatic secretagogues such as CCK (43) and 
bombesin (44), which are increased uring pancreatic regeneration (12,45). However, this effect 
may be due to a combination of all these factors and other as yet unknown ones. 
Another possible explanation for the decrease in the number of SS receptors may be that 
the regenerating pancreatic acinar cells were still immature by day 30 after reopening the PBD. 
This hypothesis i  supported by the fact that the number of SS receptors in very young rats is 
lower than in mature rats. Thus, the maturation of the SS receptor-AC system may take place in 
this context. 
Other conditions of cell regeneration such as regenerating hepatocytes i olated from 
hepatectomized livers also show a limited response to SS-14, which may be explained by a 
decrease in the binding of SS-14 to membrane-specific receptors (46). 
Although at least five SS receptor subtypes have been cloned (47) the rat pancreas appears 
to express only receptor subtype 2 (SSTR2) (48). Therefore, it is possible that the decrease in the 
SS receptor number during pancreatic regeneration could result, at least in part, from down- 
regulation of the SSTRZ subtype. 
The data reported here show that pancreatic acinar membrane SS receptors are coupled 
in an inhibitory fashion to AC, which is in agreement with previous reports (11). One month after 
reopening the closed PBD, basal and FK-stimulated AC activity were lower after reopening the 
closed PBD as compared to controls and the ability of SMS 201-995 to inhibit AC was diminished 
in acinar membranes from regenerating pancreas as compared with controls. However, there did 
not appear to be any defect in the catalytic subunit of AC itself since similar activity levels were 
noted in membranes from both control and regenerating pancreas when this enzyme was 
stimulated irectly by the diterpene FK. These results are in agreement with studies on hepatic 
regeneration (49). The attenuation of the inhibitory activity of SMS on AC activity observed in 
the present study in pancreatic acinar membranes from rats one month after reopening the closed 
PBD is most likely related to the observed loss of SS receptors and to alterations in the Gi 
proteins. 
The present observation of a decrease in the extent of PTX-catalyzed ADP-ribosylation 
in regenerating pancreatic acinar cell membranes one month after reopening the closed PBD 
suggests an impairment in the inhibitory interaction between the q protein and the AC enzyme, 
which could explain the attenuation of the inhibitory effect of SMS 201-995 on FK-stimulated AC 
activity in these membranes. Endogenous inactivation of the Gi protein has been reported in 
several cell types during regeneration and cell growth (50). Inactivation of Gi proteins could 
result from endogenous ADP-ribosylation (50) or from phosphorylation, e.g. by protein kinase 
C (51). Indeed, in a number of cell types, cell proliferation or regeneration is associated with 
increased protein kinase C activation (52). 
The fact that SS-receptor-AC system could not be detected in pancreatic acinar membranes 
fourteen hours after PBDL does not support he possibility that the beneficial effects of SS on 
pancreatitis-induced by PBDL may not be due to a direct action of the peptide on pancreatic 
acinar cell during that period. Therefore, the suggested beneficial influence of SS on PBDL- 
induced acute pancreatitis it could be ascribed to others mechanisms. These may include its 
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inhibitory effect on duodenal CCK release (4) and bile secretion (53) as well as its marked 
vascular effect in the splanchnic area (54). 
In this regard, obstruction-induced acute pancreatitis n rats is associated with a marked 
increase in circulating CCK levels (12). It has been suggested that excesive stimulation of the 
exocrine pancreas due to a marked elevation in circulating CCK concentration isa factor involved 
in the pathogenesis of PBD obstruction-induced acute pancreatitis. On the other hand, it has been 
reported that CCK diminishes the number of SS receptors in pancreatic acinar cells (43). Taken 
together, it is possible that CCK is involved in the pathogenesis of acute. pancreatitis observed in 
the present study fourteen hours after PBDL. CCK could cause this effect by directly disrupting 
acinar cell and by decreasing the SS mechanism of action. This may represent a mechanism for 
pancreatitis. 
The blockage of CCK receptors with proglumide did not modify the SS receptor-AC 
system in control rats and accelerated pancreatic regeneration one month after reopening the 
closed PBD. In addition, all parameters examined in the present study were nearly normalized. 
These facts suggest hat the given effect of proglumide on the SS-receptor-AC system is due to 
its action on pancreatic regeneration. The present study agrees with previous studies which 
indicate that specific CCK receptor antagonists have been beneficially used to protect and/or 
reduce pancreatic damage during the induction and progression of acute pancreatitis (2,3) and that 
CCK may play role in the pathogenesis of obstruction-induced acute pancreatitis (55,56). 
Acknowledgements 
The authors thank Ms. Carol F. Warren and Jerry Keller from the Alcala University 
Institution of Education Sciences and Lilian Puebla from the Department of Biochemistry of 
Alcala University for their linguistic assistance, as well as Ms. Maria Baez for her excellent 
assistance with library research and Mr. Luis Monge for assistance in the preparation of the 
illustrations. The authors are also grateful to Sandoz Ltd. (Basel, Switzerland) for generous 
donation of SMS 201-995 and its analogue Ty?-SMS. This study was supported by a Grant from 
the Direction General de Investigaci6n Cientifica y Tt!cnica (PM95-0041) and from the University 
of Alcala (001/96) of Spain. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
References 
J.H. GRENDELL, Yale J. Biol. Med @ 431-440 (1992). 
G. JURKOWSKA, G. GRONDIN and J. MORISSET, Pancreas 1295-304 (1992). 
C. NIEDERAU, L.D. FERRELL and J.H. GRENDELL, Gastroenterology 88 1192-1204 
(1985). 
Y. TORIUMI, I. SAMUEL, D.P. WILCOCKSON, C.M. TURKELSON, T.E. 
SOLOMON and R.J. JOEHL, J. Lab. Clin. Med. 122 450-454 (1993). 
G. BODEN, M.C. SIVITZ and O.E. OWEN, Science 190 163 (1975). 
V. SCHWEDES, P.H. ALTHOFF, I. KLEMPA, U. LEUSCHNER, L. MOTHES, S. 
RAPTIS, J. WDOWINSKI and K.H. USADEL, Horm. Metab. Res. 11655-661 (1979). 
J.N. BAXTER, S.A. JENKINS, D.W. DAY, N.B. ROBERTS, D.C. COWELL and C.R. 
MACKIE, Br. J. Surg. 22 382-385 (1985). 
P.G. LANKISH, H. KOOP, K. WINCKLER, U.R. FOLSCH and W. CREUTZFELDT, 
Gut u 713-716 (1977). 
C.B. SRIKANT and Y.C. PATEL, J. Biol. Chem. m 7690-7696 (1986). 
S. KNUHTSEN, J.P. ESTEVE, B. BERNADET, N. VAYSSE and C. SUSIM, 
B&hem. J. a 641-647 (1988). 
2268 Somatostatin Receptors and Acute Pancreatitis Vol. 61, No. 23, 1997 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
C.T. SAKAMOTO, T. MATOZAKI, M. NAGAO and S. BABA, Am. J. Physiol. 
(Gastroint Liver Physiol 16) 253 G308-G314 (1987). 
K.M. MURAYAMA, I. SAMUEL, Y. TORIUMI, T.E. SOLOMON, C.M. 
TURKELSON and R.J. JOEHL, J. Surg. Res. 54 126-131 (1993). 
M. RUNZI, M.K. MULLER and H. GOEBELL, Regul. Pept. 47 65-72 (1993). 
Y.C. PATEL and S. REICHLIN, Endocrinology 142 523-531 (1978). 
A. ARIMURA, H. SATO, A.DUPONT, N. NISHI and A.V. SCHALLY, Science m 
1007-1009 (1975). 
3.5. HOLST, Pancreas 2 613-619 (1987). 
A. NAKAGAWA, J.I. STAGNER and E. SAMOLS, Gastroenterology &j 868-875 
(1993). 
Y.C. PATEL, T. WHEATLEY and C. NING, Endocrinology m 1943-1949 (1981). 
L. BOQUIST and C. EDSTROM, Virchows Arch. Abt. A Path. Anat. 349 69-79 (1970). 
A. DEMBINSKI, Z. WARZECHA, S.J. KONTUREK SJ, RZ. CA1 and A.V. 
SCHALLY, J. Physiol. Pharmacol. 42 195-209 (1991). 
A. AMSTERDAM, T.E. SOLOMON and J.D. JAMIESON, Methods Cell Biol. a 361- 
378 (1978). 
J. MELDOLESI, J.D. JAMIESON and G.E. PALADE, J. Cell Biol. @ 109-129 (1971). 
O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 
193 265-275 (1951). 
B. COLAS, C. CAMBILLAU, L. BUSCAIL, M. ZEGGARI, J.P. ESTEVE, V. 
LAUTRE, F. THOMAS, N. VAYSSE and C. SUSINI, Eur. J. B&hem. 207 1017-1024 
(1992). 
J.C. REUBI, Life Sci. 36 1829-1836 (1985). 
H. ANTONIOTTI, P. FAGOT-REVURAT, J.P. ESTEVE, D. FOURMY, L. 
PRADAYROL and A. RIBET, J. Chromatogr. 296 181-188 (1984). 
M.D. HOUSLAY, J.C. METCALFE, G.P. WARREN, T.R. HESKETH and G.A. 
SMITH, B&him. Biophys. Acta. a 489-494 (1976). 
A.G. GILMAN, Proc. Natl. Acad. Sci. USA. fl 305-312 (1970). 
G.M. BOKOCH, T. KATADA, J.K. NORTHUP, E.L. HEWLETT and A.G. GILMAN, 
J. Biol. Chem. 258 2072-2075 (1983). 
U.K. LAEMMLI, Nature 227 680-685 (1970). 
M. LABURTHE, B. BREANT and C. ROUYER-FESSARD, Eur. J. B&hem. 139 181- 
187 (1984). 
F.C. GREENWOOD, W.M. HUNTER and J.S. GLOVER, B&hem. J. 89 114-123 
(1963). 
P.J. MUNSON and D. RODBARD, Anal. Biochem. 1207 220-239 (1980). 
G. SCATCHARD, Ann. N.Y. Acad. Sci. fi 669-671 (1949). 
G.T. HULTQUIST, V. KARLSSON and A.C. HALLNER, Exp. Pathol. 12 44-52 
(1979). 
G. OHSHIO, A. SALUJA, M.L. STEER, Gastroenterology 100 196-202 (1991). 
P.M. KUEPPERS, D.H. RUSSELL and F.G. MOODY, Pancreas 8 632-637 (1993). 
S. LARSEN, J. HILSTED, B. TRONIER and H. WORNING, Acta Endocrinol. 118 357- 
364 (1988). 
E. IPP, R.E. DOBBS, V. HARRIS, A. ARIMURA, W. VALE and R.H. UNGER, J. 
Clin. Invest. @ 1216-1219 (1977). 
D. ROUILLER D, V. SCHUSDZIARRA, V. HARRIS and R.H. UNGER, Endocrinology 
107 524-529 (1980). 
T. YAMADA, J. BRUNSTEDT and T. SOLOMON, Am. J. Physiol. 244 G541-G545 
(1983). 
S. HEISLER and C.B. SRIKANT, Endocrinology 117 217-225 (1985). 
Vol. 61, No. 23, 1997 Somatostatin Receptors and Acute Pancreatitis 2269 
43. 
44. 
45. 
C. SAKAMOTO, I.D. GOLDFINE and J.A. WILLIAMS, J. Biol. Chem. 259 9623-9627 
(1984). 
C.T. SAKAMOTO, T. MATOZAKI, M. NAGAO, H. NISHISAKI and S. BABA, 
Pancreas 3 18-24 (1988). 
D. PAREKH, G. G6ME2, C.M. Jr. TOWNSED and J.C. THOMPSON, 
Gastroenterology 96 A383 (1989). 
46. M. HASHIMOTO, P.C. KOTHARY and S.E. RAPER, Regul. Pept. 44 49-59 (1993). 
47. 
48. 
49. 
50. 
51. 
52. 
53. 
54. 
55. 
56. 
D. HOYER, H. LUBBERT and C. BRUNS, Naunyn Schmied Arch Pharmacol. m 441- 
453 (1994). 
J.F. BRUNO, Y. XU, J. SONG and M. BERELOWITZ, Endocrinology m 2561-2567 
(1993). 
L.G. GUIJARRO, A. COUVINEAU, M.S. RODRiGUEZ-PENA, G. JUARRANZ, N. 
RODRfGUEZ-HENCHE and E. ARILLA, B&hem. J. m 515-520 (1992). 
M. UI, F. OKAJIMA and H. ITOH, Adv. Cyclic. Nucl. Res. 19 195-205 (1985). 
T. KATADA, A.G. GILMAN, Y. WATANABE, S. BAUER and K.H. JAKOBS, Eur. 
J. Biochem. 151.431-437 (1985). 
G. KUNOS, E.J.N. ISHAC, B&hem. Pharmac. % 1185-1191 (1987). 
W.C. MEYERS. J.B. HANKS and R.S. JONES, Surgery 86 301-306 (1979). 
L. THULIN and H. SAMNERGAD, Acta Chir. Stand. s482 73-77 (1978). 
K.M. MURAYAMA, J.B. DREW, D.L. NAHRWOLD and R.J. JOEHL, Pancreas 5 
439-444 (1990). 
K.M. MURAYAMA, J.B. DREW, H. YOKOO and R.J. JOEHL, Pancreas 6 175-181 
(1991). 
